CRP and pancreatic neoplasm: Inflammation markers such as the neutrophil to lymphocyte ratio (NRL), the platelet to lymphocyte ratio (PLR), the lymphocyte to monocyte ratio (LMR) and the CRP to albumin ratio (CAR) have recently gained attention due to their potential as prognostic scores for overall survival (OS) in pancreatic cancer.